In particular, IL-6 is a key mediator in inflammation and carcinogenesis, such as EMT, metastasis and tumor microenvironment (Scheller et al., 2006; Yadav et al., 2011; Son et al., 2015). This evidence concerns the gene IL6 and neoplasm.